Review



normal human cervix epithelial cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC normal human cervix epithelial cell line
    Decreased expression of miR-1193 in cervical cancer tissues and cell lines. ( A ) Difference in the expression of miR-1193 in 60 pairs of cervical samples by qRT-PCR analysis. ( B ) Difference in the expression of miR-1193 in 60 pairs of abnormal cervical tissues (Abnormal) and matched normal tissues (Normal) by qRT-PCR analysis. ( C ) Difference in the expression of miR-1193 in LSIL (N=16), HSIL (N=16) and CC (N=28) tissues by qRT-PCR analysis. ( D ) Difference in the expression of miR-1193 in six cervical cancer cell lines (C-33A, CaSki, HCE1, Hela, Hela 229 and SiHa) and one normal human cervix <t>epithelial</t> cell line <t>(Ect1/E6E7)</t> by qRT-PCR analysis. * P <0.05, ** P <0.01. Abbreviations: LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; CC, cervical cancer.
    Normal Human Cervix Epithelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 370 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human cervix epithelial cell line/product/ATCC
    Average 96 stars, based on 370 article reviews
    normal human cervix epithelial cell line - by Bioz Stars, 2026-04
    96/100 stars

    Images

    1) Product Images from "MiR-1193 Inhibits the Malignancy of Cervical Cancer Cells by Targeting Claudin 7 (CLDN7)"

    Article Title: MiR-1193 Inhibits the Malignancy of Cervical Cancer Cells by Targeting Claudin 7 (CLDN7)

    Journal: OncoTargets and therapy

    doi: 10.2147/OTT.S247115

    Decreased expression of miR-1193 in cervical cancer tissues and cell lines. ( A ) Difference in the expression of miR-1193 in 60 pairs of cervical samples by qRT-PCR analysis. ( B ) Difference in the expression of miR-1193 in 60 pairs of abnormal cervical tissues (Abnormal) and matched normal tissues (Normal) by qRT-PCR analysis. ( C ) Difference in the expression of miR-1193 in LSIL (N=16), HSIL (N=16) and CC (N=28) tissues by qRT-PCR analysis. ( D ) Difference in the expression of miR-1193 in six cervical cancer cell lines (C-33A, CaSki, HCE1, Hela, Hela 229 and SiHa) and one normal human cervix epithelial cell line (Ect1/E6E7) by qRT-PCR analysis. * P <0.05, ** P <0.01. Abbreviations: LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; CC, cervical cancer.
    Figure Legend Snippet: Decreased expression of miR-1193 in cervical cancer tissues and cell lines. ( A ) Difference in the expression of miR-1193 in 60 pairs of cervical samples by qRT-PCR analysis. ( B ) Difference in the expression of miR-1193 in 60 pairs of abnormal cervical tissues (Abnormal) and matched normal tissues (Normal) by qRT-PCR analysis. ( C ) Difference in the expression of miR-1193 in LSIL (N=16), HSIL (N=16) and CC (N=28) tissues by qRT-PCR analysis. ( D ) Difference in the expression of miR-1193 in six cervical cancer cell lines (C-33A, CaSki, HCE1, Hela, Hela 229 and SiHa) and one normal human cervix epithelial cell line (Ect1/E6E7) by qRT-PCR analysis. * P <0.05, ** P <0.01. Abbreviations: LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; CC, cervical cancer.

    Techniques Used: Expressing, Quantitative RT-PCR



    Similar Products

    96
    ATCC normal human cervix epithelial cell line
    Decreased expression of miR-1193 in cervical cancer tissues and cell lines. ( A ) Difference in the expression of miR-1193 in 60 pairs of cervical samples by qRT-PCR analysis. ( B ) Difference in the expression of miR-1193 in 60 pairs of abnormal cervical tissues (Abnormal) and matched normal tissues (Normal) by qRT-PCR analysis. ( C ) Difference in the expression of miR-1193 in LSIL (N=16), HSIL (N=16) and CC (N=28) tissues by qRT-PCR analysis. ( D ) Difference in the expression of miR-1193 in six cervical cancer cell lines (C-33A, CaSki, HCE1, Hela, Hela 229 and SiHa) and one normal human cervix <t>epithelial</t> cell line <t>(Ect1/E6E7)</t> by qRT-PCR analysis. * P <0.05, ** P <0.01. Abbreviations: LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; CC, cervical cancer.
    Normal Human Cervix Epithelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human cervix epithelial cell line/product/ATCC
    Average 96 stars, based on 1 article reviews
    normal human cervix epithelial cell line - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    98
    ATCC human cervix epithelial cell line
    Higher expression of SNHG7 correlates with poor clinical outcomes among patients with cervical cancer. ( A ) The expression of SNHG7 was measured by RT-qPCR in 51 pairs of cervical cancer tissue samples and the corresponding adjacent normal tissues. *P < 0.05 vs adjacent normal tissues. ( B ) Kaplan–Meier analysis illustrates the 5-year survival rates of patients with cervical cancer in the high -SNHG7 expression group (n = 26) and low- SNHG7 expression group (n = 25). P = 0.024. ( C ) The expression of SNHG7 in four cervical cancer cell lines (HeLa, SiHa, C-33A, and CaSki) and in normal human cervix <t>epithelial</t> cell line Ect1/E6E7 was analyzed via RT-qPCR. *P < 0.05 vs the Ect1/E6E7 group.
    Human Cervix Epithelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cervix epithelial cell line/product/ATCC
    Average 98 stars, based on 1 article reviews
    human cervix epithelial cell line - by Bioz Stars, 2026-04
    98/100 stars
      Buy from Supplier

    Image Search Results


    Decreased expression of miR-1193 in cervical cancer tissues and cell lines. ( A ) Difference in the expression of miR-1193 in 60 pairs of cervical samples by qRT-PCR analysis. ( B ) Difference in the expression of miR-1193 in 60 pairs of abnormal cervical tissues (Abnormal) and matched normal tissues (Normal) by qRT-PCR analysis. ( C ) Difference in the expression of miR-1193 in LSIL (N=16), HSIL (N=16) and CC (N=28) tissues by qRT-PCR analysis. ( D ) Difference in the expression of miR-1193 in six cervical cancer cell lines (C-33A, CaSki, HCE1, Hela, Hela 229 and SiHa) and one normal human cervix epithelial cell line (Ect1/E6E7) by qRT-PCR analysis. * P <0.05, ** P <0.01. Abbreviations: LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; CC, cervical cancer.

    Journal: OncoTargets and therapy

    Article Title: MiR-1193 Inhibits the Malignancy of Cervical Cancer Cells by Targeting Claudin 7 (CLDN7)

    doi: 10.2147/OTT.S247115

    Figure Lengend Snippet: Decreased expression of miR-1193 in cervical cancer tissues and cell lines. ( A ) Difference in the expression of miR-1193 in 60 pairs of cervical samples by qRT-PCR analysis. ( B ) Difference in the expression of miR-1193 in 60 pairs of abnormal cervical tissues (Abnormal) and matched normal tissues (Normal) by qRT-PCR analysis. ( C ) Difference in the expression of miR-1193 in LSIL (N=16), HSIL (N=16) and CC (N=28) tissues by qRT-PCR analysis. ( D ) Difference in the expression of miR-1193 in six cervical cancer cell lines (C-33A, CaSki, HCE1, Hela, Hela 229 and SiHa) and one normal human cervix epithelial cell line (Ect1/E6E7) by qRT-PCR analysis. * P <0.05, ** P <0.01. Abbreviations: LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; CC, cervical cancer.

    Article Snippet: Six cervical cancer cell lines (C-33A, CaSki, HCE1, Hela, Hela 229 and SiHa) and one normal human cervix epithelial cell line (Ect1/E6E7) were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA).

    Techniques: Expressing, Quantitative RT-PCR

    Higher expression of SNHG7 correlates with poor clinical outcomes among patients with cervical cancer. ( A ) The expression of SNHG7 was measured by RT-qPCR in 51 pairs of cervical cancer tissue samples and the corresponding adjacent normal tissues. *P < 0.05 vs adjacent normal tissues. ( B ) Kaplan–Meier analysis illustrates the 5-year survival rates of patients with cervical cancer in the high -SNHG7 expression group (n = 26) and low- SNHG7 expression group (n = 25). P = 0.024. ( C ) The expression of SNHG7 in four cervical cancer cell lines (HeLa, SiHa, C-33A, and CaSki) and in normal human cervix epithelial cell line Ect1/E6E7 was analyzed via RT-qPCR. *P < 0.05 vs the Ect1/E6E7 group.

    Journal: OncoTargets and therapy

    Article Title: Long Noncoding RNA SNHG7, a Molecular Sponge for microRNA-485, Promotes the Aggressive Behavior of Cervical Cancer by Regulating PAK4

    doi: 10.2147/OTT.S232542

    Figure Lengend Snippet: Higher expression of SNHG7 correlates with poor clinical outcomes among patients with cervical cancer. ( A ) The expression of SNHG7 was measured by RT-qPCR in 51 pairs of cervical cancer tissue samples and the corresponding adjacent normal tissues. *P < 0.05 vs adjacent normal tissues. ( B ) Kaplan–Meier analysis illustrates the 5-year survival rates of patients with cervical cancer in the high -SNHG7 expression group (n = 26) and low- SNHG7 expression group (n = 25). P = 0.024. ( C ) The expression of SNHG7 in four cervical cancer cell lines (HeLa, SiHa, C-33A, and CaSki) and in normal human cervix epithelial cell line Ect1/E6E7 was analyzed via RT-qPCR. *P < 0.05 vs the Ect1/E6E7 group.

    Article Snippet: Ect1/E6E7, a normal human cervix epithelial cell line, was purchased from the American Type Culture Collection (Manassas, VA, USA).

    Techniques: Expressing, Quantitative RT-PCR